AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 1.98 |
Market Cap | 4.03M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -8.24 |
PE Ratio (ttm) | -0.24 |
Forward PE | n/a |
Analyst | Buy |
Ask | 2.13 |
Volume | 14,728 |
Avg. Volume (20D) | 189,241 |
Open | 2.02 |
Previous Close | 2.02 |
Day's Range | 1.94 - 2.02 |
52-Week Range | 1.70 - 18.15 |
Beta | undefined |
About STSS
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York....
Analyst Forecast
According to 1 analyst ratings, the average rating for STSS stock is "Buy." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.
8 months ago · https://www.defenseworld.net
Head-To-Head Analysis: NeuroMetrix (NASDAQ:NURO) & Sharps Technology (NASDAQ:STSS)NeuroMetrix (NASDAQ:NURO – Get Free Report) and Sharps Technology (NASDAQ:STSS – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast t...